Abiopharma

New Form 8-K - Cyclacel Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026110 Size: 655 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits